I am a social scientist by training and my research interest are focussed around exploring the socioeconomic factors associated with neonatal encephalopathy. I am the program manager for a the PREVENT (Prevention of Epilepsy by reducing Neonatal Encephalopathy) study funded by NIHR. I am also the Deputy Director for the Centre for Perinatal Neuroscience at Imperial College London.
Pant S, 2021, Parental and professional perceptions of informed consent and participation in a time-critical neonatal trial in Low and Middle-income countries: A mixed methods study, Bmj Global Health, Vol:6, ISSN:2059-7908, Pages:1-9
et al., 2021, Association of Total Sarnat Score with brain injury and neurodevelopmental outcomes after neonatal encephalopathy, Archives of Disease in Childhood: Fetal and Neonatal Edition, ISSN:1359-2998
et al., 2021, Erythropoietin monotherapy for neuroprotection after neonatal encephalopathy in low 2 to-middle income countries: A systematic review and meta-analysis, Journal of Perinatology, ISSN:0743-8346
et al., 2021, Informed consent rates for neonatal randomized controlled trials in low- and lower middle-income versus high-income countries: a systematic review, Plos One, Vol:16, ISSN:1932-6203, Pages:1-14
et al., 2020, Transcriptomic profile of adverse neurodevelopmental outcomes after neonatal encephalopathy, Scientific Reports, Vol:10, ISSN:2045-2322, Pages:1-7